Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.36 HKD | +1.66% | +3.61% | -22.04% |
Apr. 22 | Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine | MT |
Apr. 22 | Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.04% | 1.06B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+55.83% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
+7.34% | 8.31B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- WHO Grants Emergency Use Authorization to CanSino Bio's COVID Vaccine; Shares Rally 13%